J.-C. Ongagna

Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes

J.-C. Ongagna, M. Pinget, A. Belcourt · Clinical Biochemistry · 2005 · 45 citations

Life Sciences, Endocrinology, Genetics +12

A prospective observational post‐marketing study of natalizumab‐treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The <scp>BIONAT</scp> cohort

Olivier Outteryck, J.-C. Ongagna, Bruno Brochet et al. · European Journal of Neurology · 2013 · 41 citations

Medicine, Clinical Sciences, Neurology +15

Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients

M. Martinot, Magali Eyriey, Simon Gravier et al. · Infectious Diseases Now · 2021 · 41 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +14

Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice

Olivier Outteryck, J.-C. Ongagna, Hélène Zéphir et al. · Journal of Neurology · 2009 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +4

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients

Laure Michel, Sandra Vukusic, J. de Sèze et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 39 citations

Pharmacy, Neurology, Pharmacotherapy +15